Could a pill ease psoriasis? new study investigates roflumilast
NCT ID NCT07233291
First seen Nov 18, 2025 · Last updated May 16, 2026 · Updated 19 times
Summary
This study is testing an oral medication called roflumilast to see if it can safely reduce psoriasis symptoms in adults with moderate-to-severe plaque psoriasis. Over 12 weeks, 36 participants will take the drug daily, starting with a low dose and increasing it. The main goal is to measure changes in skin severity using a standard scoring system, along with monitoring side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS (PSO) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mansoura University Hospital
RECRUITINGAl Mansurah, Dakahlia Governorate, 35511, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.